Illumina

📍 San Diego, United States🗓 Founded 1998👥 9,559 employees💰 Last funded Apr 2024
Biotechnology Research🌐 illumina.com
Website LinkedIn
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
4
Total investors
1
Early stage
0
Mid stage
1
Late stage
1998
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Italy
1
Investor activity1999–2024 · investors recorded per year
19991200512019120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Illumina?
Illumina has 4 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Illumina last raise funding?
The most recent investment in Illumina recorded on gritt.io was in April 2024.
When was Illumina founded?
Illumina was founded in 1998.
What industry is Illumina in?
Illumina operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Illumina based?
Illumina is headquartered in San Diego, United States.